Arrowhead Pharmaceuticals Inc. (ARWR)
NASDAQ · Healthcare
Arrowhead Pharmaceuticals Inc. Operating Income 2011–2025
Arrowhead Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Arrowhead Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was -141.3 M, a 137.06% decrease year-over-year.
- Arrowhead Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was 115.2 M, a 119.19% decrease year-over-year.
- Arrowhead Pharmaceuticals Inc. annual operating income for 2025 was 98.3 M, a 116.36% decrease from 2024.
- Arrowhead Pharmaceuticals Inc. annual operating income for 2024 was -601.1 M, a 193.21% increase from 2023.
- Arrowhead Pharmaceuticals Inc. annual operating income for 2023 was -205.0 M, a 14.84% increase from 2022.
- Arrowhead Pharmaceuticals Inc. annual operating income for 2022 was -178.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Arrowhead Pharmaceuticals Inc. Operating Income — FAQ
Arrowhead Pharmaceuticals Inc. (ARWR) operating income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Arrowhead Pharmaceuticals Inc.'s operating income?
Arrowhead Pharmaceuticals Inc. (ARWR) reported operating income of $98M for fiscal 2025.
Where can I see ARWR's operating income history?
The chart and table above show Arrowhead Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.